Komori
KYORIN Pharmaceutical (4569) · InitiativeFirst stated

Acquisition of co-promotion rights for Alesion ophthalmic cream

First written in FY2027-H1. . Latest entry: FY2027-H1.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Co-promotion of Alesion Ophthalmic Ointment with Santen PharmaceuticalA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for KYORIN Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Acquisition of co-promotion rights for Alesion ophthalmic cream | KYORIN Pharmaceutical Co.,Ltd. (4569) | Komori